With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK. | ...
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025 ...
10don MSN
Emergent BioSolutions wins FDA approval for new Narcan multipacks to expand overdose access
Emergent BioSolutions Inc. EBS stock rose Friday following the FDA approval of new multipack configurations of ...
Emergent BioSolutions received Food and Drug Administration approval for its multipack configuration of Narcan, the opioid-overdose-reversal drug.
Approval will broaden the NARCAN® Nasal Spray portfolio, and improve cost-effectiveness byincreasing flexibility and distribution efficiency of ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...
Immigration and Customs Enforcement has come under fire after a second person was killed by federal agents in Minneapolis, with protesters demanding an end to additional federal funding ahead of a ...
Homebuyers canceled their purchase agreements at the highest rate on record in December, another signal of a housing market mired in uncertainty. More than 40,000 home-purchase agreements were ...
The Treasury Department cut ties with Booz Allen Hamilton on Monday and announced that it was canceling $21 million in federal contracts with the consulting giant because one of its ex-employees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results